Search for: "Electric Co. v. Dow" Results 1 - 20 of 77
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2024, 8:22 am by admin
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [6] General Electric Co. v. [read post]
23 Dec 2023, 7:16 pm by admin
Joiner had been an electrician by a small city in Georgia, where he experienced dermal exposure, over several years, to polychlorinated biphenyls (PCB’s), a chemical found in electrical transformer coolant. [read post]
29 Jun 2023, 12:29 am by Roel van Woudenberg
The appellant argues that, owing to the absence of sufficient information on how to determine that amount, claim 1 lacks sufficiency of disclosure.2.1 It is undisputed that the presence of aluminium in the ethylene/alpha-olefin copolymer is taught to find its origin in the use of an organic aluminumoxy compound or organic aluminium compound added as co-catalyst for the polymerisation of the ethylene/alpha-olefin copolymer (page 4, lines 12-15 and paragraph 44 of the patent in suit),… [read post]
11 Nov 2022, 2:46 pm by admin
Merrell Dow Pharms., Inc., 509 U.S. 579, 595 (1993). [5] General Electric Co. v. [read post]
12 Dec 2021, 2:22 pm by admin
Supreme Court General Electric Co. v. [read post]
8 May 2020, 3:47 am by Schachtman
D.C. 46, 293 F. 1013 (1923). [3]  See “The Advocates’ Errors in Daubert” (Dec. 28, 2018). [4]  General Electric Co. v. [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
21 Oct 2017, 9:00 am by W.F. Casey Ebsary, Jr.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]